個股熱度排行 | 3月31日港股盤前
根據uSMART輿情監測數據，從30日晚間到31日港股盤前時間段，市場關注指數最高的5只股票是萬科企業、大衆公用、中國中車、快手-W、昭衍新藥。
3月31日—港股關注排行TOP5
萬科企業
關注度第一爲萬科企業，該股上個交易日收盤上漲6.67%，報於17.92港元。近5個交易日累計上漲2.40%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
萬科企業全年歸屬於股東淨利潤225.24億元 同比下降45.75%
萬科全年純利225.24億人民幣跌45.8% 派息97分
大衆公用
關注度第二爲大衆公用，該股上個交易日收盤持平，報於1.60港元。近5個交易日累計下跌1.23%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
大衆公用發佈2021年業績，淨利潤3.03億元，同比減少41.12%，每10股派0.5元
大衆公用2021年度計提各項減值準備3770.38萬元
中國中車
關注度第三爲中國中車，該股上個交易日收盤上漲2.87%，報於3.23港元。近5個交易日累計下跌0.31%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
中國中車發佈2021年業績，淨利潤103.03億元，降幅爲9.08%，每10股派1.8元
中國中車2022年度擔保安排：擬對下屬子公司提供1336.40億元擔保
快手-W
關注度第四爲快手-W，該股上個交易日收盤下跌6.24%，報於73.60港元。近5個交易日累計下跌8.23%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
快手-W授出1623.998萬份購股權
快手巨震16%！官方出手，這一直播打賞方式行不通了
昭衍新藥
關注度第五爲昭衍新藥，該股上個交易日收盤上漲5.80%，報於74.80港元。近5個交易日累計上漲11.64%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
昭衍新藥發佈2021年業績 淨利潤5.57億元 同比增76.96% 每10股轉4股派3.6元
昭衍新藥擬斥2億元認購廈門源峯基金份額
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
